Effectiveness of a Digital Therapeutic for Enhancement of the Quality of Life of People with Cancer (lancivis): a randomized controlled trial
Phase 4
- Conditions
- C00-C97Malignant neoplasms
- Registration Number
- DRKS00027057
- Lead Sponsor
- GAIA AG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 604
Inclusion Criteria
diagnosis of cancer (ICD-10: C00 – C97, verified by physician’s document)
impaired quality of life (FACT-G total score = 81)
consent to participation
Exclusion Criteria
none
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method